SCISPARC LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.2 USD | -4.00% |
|
-3.23% | -75.41% |
| Apr. 11 | SciSparc Ltd. signed a merger agreement to acquire remaining stake in Automax Motors Ltd. | CI |
| Apr. 01 | SciSparc Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Financials (USD)
| Sales 2022 | 1.35 | Sales 2023 | 2.88 | Capitalization | 2.56M |
|---|---|---|---|---|---|
| Net income 2022 | -2M | Net income 2023 | -5M | EV / Sales 2022 | 1,145,812 x |
| Net cash position 2022 | 3.55M | Net cash position 2023 | 5M | EV / Sales 2023 | -848,893 x |
| P/E ratio 2022 |
-1.33
x | P/E ratio 2023 |
-0.34
x | Employees | 3 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.98% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -4.00% | ||
| 1 week | -3.23% | ||
| Current month | -14.29% | ||
| 1 month | -19.46% | ||
| 3 months | -66.10% | ||
| 6 months | -81.42% | ||
| Current year | -75.41% |
1 week
1.20
1.30
1 month
1.151.44
Current year
1.156.78
1 year
1.1523.66
3 years
0.00221.00
5 years
0.00221.00
10 years
0.00221.00
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-15 | 1.2 | -4.00% | 111,044 |
| 24-05-14 | 1.25 | 0.00% | 100,297 |
| 24-05-13 | 1.25 | 0.00% | 35,456 |
| 24-05-10 | 1.25 | -2.34% | 57,190 |
| 24-05-09 | 1.28 | +3.23% | 28,497 |
Delayed Quote Nasdaq, May 15, 2024 at 04:30 pm EDT
More quotes
Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The company is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.
Sector
Pharmaceuticals
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -75.41% | 3.24M | |
| +21.98% | 43.92B | |
| +24.56% | 23.09B | |
| +19.25% | 15.35B | |
| +14.03% | 13.61B | |
| +46.40% | 12.02B | |
| -10.14% | 7B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +13.07% | 5.6B |
- Stock Market
- Equities
- SPRC Stock